Relaxin affects the central control of oxytocin release.
In several species the myometrium is quiescent shortly before parturition. At this time high titres of relaxin are present in the plasma and there is evidence that the hormone has a direct inhibitory action on the uterine muscle. Relaxin could also contribute to uterine quiescence by inhibiting oxytocin release. To determine whether relaxin has a central action on the release of oxytocin, we have studied the effect of intravenous injections of porcine relaxin on milk ejection in the anaesthetized lactating rat. We report that reflex milk ejection was suppressed by relaxin in a dose-dependent manner, the onset of inhibition being rapid and lasting from 10 to 60 min. After the period of inhibition the normal temporal pattern of reflex milk ejection was resumed. Mammary sensitivity to exogenous or endogenous oxytocin was reduced by relaxin but not sufficiently to explain the effects observed. Furthermore, relaxin (1 microgram per rat) injected into the cerebral ventricles profoundly disturbed the pattern of reflex milk ejection without affecting the response of the mammary gland to oxytocin. These results suggest a novel role for relaxin within the central nervous system. The site in the brain at which the effects of relaxin are exerted remains unknown.
D000818:Animals; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007276:Injections, Intraventricular; D007774:Lactation / Q000187:drug effects*; D008321:Mammary Glands, Animal / Q000378:metabolism; D008893:Milk Ejection / Q000187:drug effects*; D010121:Oxytocin / Q000378:metabolism* / Q000494:pharmacology; D011247:Pregnancy; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012065:Relaxin / Q000008:administration & dosage / Q000494:pharmacology*; D013552:Swine
D010121:Oxytocin; D012065:Relaxin